Found 272 matching trials
A Study of AK104( an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer PHASE2 This is a multicenter, open-label, phase II clinical study conducted in Chi...
Show More Location
Hunan Cancer Hospital
Learn More & Join Trial
A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer PHASE1 This is a single center, open-label, nonrandomized, phase 1b study of TRC10...
Show More Location
UAB Comprehensive Cancer Center
Learn More & Join Trial
Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer PHASE1 RATIONALE: Drugs used in chemotherapy, such as hydroxychloroquine, carbopla...
Show More Location
Cancer Institute of New Jersey at Hamilton
Learn More & Join Trial
Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC PHASE3 This randomized, Phase III, multicenter, open-label study designed to evalu...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients PHASE2 The most likely way to improve survival and cure rates in treating ovarian ...
Show More Location
Gynecologic Oncology Associates
Learn More & Join Trial
Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients PHASE2 A phase II Study of an adapted chemotherapy regimen plus bevacizumab in eld...
Show More Location
Hospital Virgen de los Lirios
Learn More & Join Trial
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer PHASE3 This randomized phase III trial studies carboplatin given together with pac...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer (TASUKI-52) PHASE3 The purpose of study is to compare the efficacy and safety of ONO-4538 in c...
Show More Location
Aichi Clinical Site2
Learn More & Join Trial
A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) PHASE3 This is a multicenter, multinational, double-blind, 1:1 randomized, paralle...
Show More Learn More & Join Trial
Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer PHASE2 To compare outcomes between the CRS group and the control group in patients...
Show More Location
National Cancer Center, Korea
Learn More & Join Trial